Chemed (CHE) total liabilities

Total liabilities · fiscal 2025
$558.78M

Chemed (CHE) had total liabilities of $558.78M at the end of fiscal 2025 (December 31, 2025). That is 1.7% higher than the $549.58M of fiscal 2024. Figures as of 19 Nov 2026, 00:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$558.78M
Change on fiscal 2024
+1.7%
Growth, 5 years
+0.9% a year
Growth, 10 years
+5.1% a year
Highest on record
$719.45Mfiscal 2021
Lowest on record
$339.07Mfiscal 2015
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Chemed total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 0.9% a year; over ten years the rate was 5.1% a year. Across the 17 fiscal years on record (2009–2025), the highest was $719.45M in fiscal 2021 and the lowest $339.07M in fiscal 2015.

History · 17 fiscal years

Total liabilities by fiscal year

Chemed total liabilities, year by year

Chemed (CHE) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$558.78M 1.7% up
2024$549.58M 1.9% down
2023$560.22M 12.9% down
2022$643.30M 10.6% down
2021$719.45M 34.8% up
2020$533.71M 1.5% down
2019$541.71M 41.0% up
2018$384.20M 1.2% up
2017$379.67M 6.7% up
2016$355.96M 5.0% up
2015$339.07M 17.0% down
2014$408.58M 8.1% down
2013$444.81M 9.5% up
2012$406.34M 6.3% up
2011$382.22M 3.8% up
2010$368.11M 7.5% up
2009$342.31M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Chemed and comparable companies
CompanyTotal liabilitiesFiscal year
Immunovant IMVT$104.42M2026
Axsome Therapeutics AXSM$601.51M2025
Chemed CHE$558.78M2025
Oruka Therapeutics ORKA$16.69M2025
Arrowhead Pharmaceuticals ARWR$1.69B2026
MSA Safety MSA$1.19B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CHE

Chemed, figure by figure

Chemed (CHE) overview: price, valuation and scorecardAll health care companies by market value

Chemed total liabilities: questions and answers

How large are Chemed's total liabilities?

Chemed (CHE) had total liabilities of $558.78M at the end of fiscal 2025 (December 31, 2025). That is 1.7% higher than the $549.58M of fiscal 2024.

What is the growth rate of Chemed's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 0.9% a year; over ten years the rate was 5.1% a year.

What are the highest and lowest total liabilities figures on record for Chemed?

Across the 17 fiscal years on record (2009–2025), the highest was $719.45M in fiscal 2021 and the lowest $339.07M in fiscal 2015.

How is Chemed's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Chemed it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Chemed (CHE) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/CHE/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.